Options to purchase securities

September 4, 2026 BSE Limited N a t i o nal Stock Exchange of India Limited Phiroze Jeejeebhoy Towers, Exchange Plaza, Bandra – Kurla Complex, Dalal Street, Mumbai - 400023 Bandra (E), BSE Code: 532926 Mumbai - 400051 Scrip Code: JYOTHYLAB Dear Sir / Madam, Sub.: Intimation for Grant of Restricted Stock Units under Jyothy Labs Limited- Employee Stock Unit Plan 2023 (“RSU Plan 2023”) [Grant-5 (September 2026)] Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform you that the Nomination, Remuneration and Compensation Committee (“NRCC”) of the Company at its meeting held today i.e. September 4, 2026 approved the grant of 1,46,141 Restricted Stock Units (“RSUs”) [Grant-5 (September 2026)] exercisable into 1,46,141 equity shares of the Company of face value of Re. 1/- each fully paid-up to selected employees of the Company as determined by NRCC, in terms of the RSU Plan 2023. The requisite disclosure as per Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 read with SEBI Circular No. HO/49/14/14(7)2025-CFD-POD2/I/3762/2026 dated January 30, 2026, is as under: a) Brief details of options granted The Board of Directors and Shareholders of the Company have approved the RSU Plan 2023 on June 9, 2023 and July 25, 2023 respectively. The NRCC of the Company on September 4, 2026, has approved grant of 1,46,141 Restricted Stock Units exercisable into 1,46,141 equity shares of the Company of face value of Re. 1/- each fully paid-up to eligible employees of the Company as determined by the NRCC, in terms of the RSU Plan 2023. b) Whether the Scheme is in terms of SEBI Yes (Share Based Employee Benefits and Sweat Equity) Regulations, 2021 (if applicable) Jyothy Labs Limited CIN: L24240MH1992PLC128651 ‘Ujala House’, Ramkrishna Mandir Road, Kondivita, Andheri (East), Mumbai 400059. Tel: +91 022-6689 2800 info@jyothy.com | www.jyothylabs.com c) Total number of shares covered by these 1,46,141 equity shares of Re. 1/- each of the Options Company. d) Pricing Formula At face value of the equity share of the Company as on date of exercise of RSUs. e) Options Vested RSUs shall vest after the minimum vesting period of 1 (one) year but not later than the maximum period of 4 (four) years from the date of grant of RSUs subject to fulfillment of performance conditions. f) Time within which Options may be RSU Plan 2023 provides that the vested exercised RSUs shall be exercised, while in employment, within a period of 2 (two) years from the date of vesting of such RSUs. In case of separation from employment, the exercise period will be as provided in the Plan. g) options exercised Nil at this stage h) money realized by exercise of options Nil i) the total number of shares arising as a Nil result of exercise of option j) options lapsed Not applicable at this stage for this particular grant k) variation of terms of options Not applicable l) brief details of significant terms RSUs granted under the Jyothy Labs Limited – Employees Stock Unit Plan 2023 (RSU 2023), administered by the NRCC. Exercise price is the face value of the Company's equity shares as on the date of grant, i.e. Re. 1 per RSU, each RSU being convertible on exercise into one equity share of Re. 1 each, fully paid-up. Vesting is not earlier than one year and not later than four years from the date of grant, subject to continued employment and to achievement of corporate performance conditions specified in the letter of grant. Vested RSUs are exercisable within a maximum of two years from the date of last vesting, on payment of the exercise price and applicable taxes, and lapse if not so exercised. The Plan is implemented directly by the Company through a fresh issue of equity shares. m) subsequent changes or cancellation or Not applicable exercise of such options Jyothy Labs Limited CIN: L24240MH1992PLC128651 ‘Ujala House’, Ramkrishna Mandir Road, Kondivita, Andheri (East), Mumbai 400059. Tel: +91 022-6689 2800 info@jyothy.com | www.jyothylabs.com n) diluted earnings per share pursuant to Not applicable issue of equity shares on exercise of options Kindly take the above on your record and disseminate the same for the information of investors. Thanking you. Yours faithfully, For Jyothy Labs Limited Shreyas Trivedi Head – Legal & Company Secretary Jyothy Labs Limited CIN: L24240MH1992PLC128651 ‘Ujala House’, Ramkrishna Mandir Road, Kondivita, Andheri (East), Mumbai 400059. Tel: +91 022-6689 2800 info@jyothy.com | www.jyothylabs.com